Ernexa Therapeutics Inc. Warrants
- ERNAW
- NASDAQ
- Biotechnology
- Stem Cell Therapy
- Oncology/Autoimmune Biotech
$0.03
Today −0.40%Quote Oct 15, 2026, 07:24 PM UTC
−30.39%over the last month
Max drawdown −34.5%From 1-month high −34.5%3 months −77.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$41,136.757
Quote Oct 15
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$0.03
0.2% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ERNAWPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5
Founded
2018